Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Storer

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
ACS Medicinal Chemistry Letters|June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain BindersJeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Journal of Medicinal Chemistry|December 17, 2016
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and SkinPeter Jones, R Ian Storer, Yogesh A Sabnis, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction MixturesMateusz P Plesniak, Emilia K Taylor, Frederik Eisele, et al.
ACS Chemical Biology|September 13, 2022
Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β BromodomainsAngelina R Sekirnik, Jessica K Reynolds, Larissa See, et al.
Journal of Medicinal Chemistry|March 21, 2024
Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional DegradersSimon C C Lucas, Afshan Ahmed, S Neha Ashraf, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 17, 2015
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014Alexander Heifetz, Gebhard F X Schertler, Roland Seifert, et al.
ACS Medicinal Chemistry Letters|July 17, 2024
Fragment-Based Discovery of Novel MUS81 InhibitorsGavin W Collie, Ulf Börjesson, Yunhua Chen, et al.
Journal of Medicinal Chemistry|June 1, 2014
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptorsR Ian Storer, Paul E Brennan, Alan D Brown, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2017
Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probesR Ian Storer, Andy Pike, Nigel A Swain, et al.
Journal of Medicinal Chemistry|September 18, 2024
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 InhibitorsSimon C C Lucas, J Henry Blackwell, Ulf Börjesson, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain BindersJeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Journal of Medicinal Chemistry|December 17, 2016
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and SkinPeter Jones, R Ian Storer, Yogesh A Sabnis, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction MixturesMateusz P Plesniak, Emilia K Taylor, Frederik Eisele, et al.
ACS Chemical Biology|September 13, 2022
Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β BromodomainsAngelina R Sekirnik, Jessica K Reynolds, Larissa See, et al.
Journal of Medicinal Chemistry|March 21, 2024
Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional DegradersSimon C C Lucas, Afshan Ahmed, S Neha Ashraf, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 17, 2015
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014Alexander Heifetz, Gebhard F X Schertler, Roland Seifert, et al.
ACS Medicinal Chemistry Letters|July 17, 2024
Fragment-Based Discovery of Novel MUS81 InhibitorsGavin W Collie, Ulf Börjesson, Yunhua Chen, et al.
Journal of Medicinal Chemistry|June 1, 2014
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptorsR Ian Storer, Paul E Brennan, Alan D Brown, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2017
Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probesR Ian Storer, Andy Pike, Nigel A Swain, et al.
Journal of Medicinal Chemistry|September 18, 2024
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 InhibitorsSimon C C Lucas, J Henry Blackwell, Ulf Börjesson, et al.
Pageof 5